(BIRK) Birkenstock Holding - Overview

Sector: Consumer Cyclical | Industry: Footwear & Accessories | Exchange: NYSE (USA) | Market Cap: 7.610m USD | Total Return: -15.7% in 12m

Sandals, Closed-Toe Shoes, Skincare, Accessories
Total Rating 41
Safety 79
Buy Signal -0.32
Footwear & Accessories
Industry Rotation: +14.8
Market Cap: 7.61B
Avg Turnover: 87.5M
Risk 3d forecast
Volatility42.6%
VaR 5th Pctl7.07%
VaR vs Median0.81%
Reward TTM
Sharpe Ratio-0.23
Rel. Str. IBD25
Rel. Str. Peer Group40.9
Character TTM
Beta0.912
Beta Downside0.801
Hurst Exponent0.466
Drawdowns 3y
Max DD50.94%
CAGR/Max DD-0.02
CAGR/Mean DD-0.04
EPS (Earnings per Share) EPS (Earnings per Share) of BIRK over the last years for every Quarter: "2021-09": null, "2021-12": null, "2022-03": null, "2022-06": null, "2022-09": null, "2022-12": null, "2023-03": null, "2023-06": 0.4215, "2023-09": 0.15, "2023-12": 0.09, "2024-03": 0.41, "2024-06": 0.49, "2024-09": 0.29, "2024-12": 0.18, "2025-03": 0.55, "2025-06": 0.62, "2025-09": 0.51, "2025-12": 0.27, "2026-03": 0.5,
Last SUE: -1.78
Qual. Beats: -1
Revenue Revenue of BIRK over the last years for every Quarter: 2021-09: 962.125, 2021-12: 271.279, 2022-03: 271.279, 2022-06: 378.667, 2022-09: 321.608, 2022-12: 248.49, 2023-03: 395.683, 2023-06: 473.195, 2023-09: 374.543, 2023-12: 302.924, 2024-03: 481.244, 2024-06: 564.758, 2024-09: 455.764, 2024-12: 361.719, 2025-03: 574.33, 2025-06: 635.042, 2025-09: 526.338, 2025-12: 401.901, 2026-03: 628.50128,
Rev. CAGR: 17.44%
Rev. Trend: 99.4%
Last SUE: 0.29
Qual. Beats: 0

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Description: BIRK Birkenstock Holding

Birkenstock Holding plc is a global footwear manufacturer and retailer specializing in footbed-based products, including sandals and closed-toe shoes. Founded in 1774 and headquartered in London, the company distributes its portfolio through a vertically integrated model encompassing e-commerce, owned retail locations, and business-to-business wholesale channels.

The company operates within the premium footwear sector, where brand equity and proprietary manufacturing processes serve as significant barriers to entry. Birkenstocks business model relies heavily on its signature cork-latex footbed, a functional design element that distinguishes its anatomical footwear from mass-market fashion competitors.

For a more detailed analysis of the companys financial health and valuation metrics, consider reviewing the comprehensive data available on ValueRay.

Headlines to Watch Out For
  • Direct-to-consumer channel expansion improves gross margins and brand control
  • Shift toward closed-toe footwear reduces seasonal revenue volatility
  • Production capacity expansion in Germany scales to meet global demand
  • Rising raw material and labor costs pressure manufacturing profit margins
  • Market share growth in Asia Pacific drives long-term revenue diversification
Piotroski VR-10 (Strict) 7.5
Net Income: 356.9m TTM > 0 and > 6% of Revenue
FCF/TA: 0.06 > 0.02 and ΔFCF/TA -0.16 > 1.0
NWC/Revenue: 42.65% < 20% (prev 42.97%; Δ -0.31% < -1%)
CFO/TA 0.08 > 3% & CFO 429.0m > Net Income 356.9m
Net Debt (1.40b) to EBITDA (672.0m): 2.08 < 3
Current Ratio: 2.95 > 1.5 & < 3
Outstanding Shares: last quarter (183.9m) vs 12m ago -2.09% < -2%
Gross Margin: 56.10% > 18% (prev 0.59%; Δ 5.55k% > 0.5%)
Asset Turnover: 43.00% > 50% (prev 38.93%; Δ 4.06% > 0%)
Interest Coverage Ratio: 8.00 > 6 (EBITDA TTM 672.0m / Interest Expense TTM 68.7m)
Altman Z'' 2.89
A: 0.18 (Total Current Assets 1.42b - Total Current Liabilities 480.5m) / Total Assets 5.17b
B: 0.17 (Retained Earnings 899.3m / Total Assets 5.17b)
C: 0.11 (EBIT TTM 549.5m / Avg Total Assets 5.10b)
D: 0.40 (Book Value of Equity 901.8m / Total Liabilities 2.27b)
Altman-Z'' = 2.89 = A
Beneish M -2.91
DSRI: 1.04 (Receivables 303.1m/260.1m, Revenue 2.19b/1.96b)
GMI: 1.05 (GM 56.10% / 58.99%)
AQI: 0.94 (AQ_t 0.61 / AQ_t-1 0.65)
SGI: 1.12 (Revenue 2.19b / 1.96b)
TATA: -0.01 (NI 356.9m - CFO 429.0m) / TA 5.17b)
Beneish M = -2.91 (Cap -4..+1) = A
What is the price of BIRK shares?

As of May 30, 2026, the stock is trading at USD 45.07 with a total of 2,769,067 shares traded.
Over the past week, the price has changed by +13.61%, over one month by +20.19%, over three months by +8.21% and over the past year by -15.65%.

Is BIRK a buy, sell or hold?

Birkenstock Holding has received a consensus analysts rating of 4.55. Therefore, it is recommended to buy BIRK.

  • StrongBuy: 15
  • Buy: 4
  • Hold: 3
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the BIRK price?
Analysts Target Price 52.1 15.6%
Birkenstock Holding (BIRK) - Fundamental Data Overview as of 27 May 2026
Market Cap USD = 7.61b (7.61b USD * 1.0 USD.USD)
Market Cap EUR = 6.53b (7.61b USD * 0.8577 USD.EUR)
P/E Trailing = 18.5561
P/E Forward = 17.6678
P/S = 3.4883
P/B = 2.2641
P/EG = 1.4033
Revenue TTM = 2.19b EUR
EBIT TTM = 549.5m EUR
EBITDA TTM = 672.0m EUR
Long Term Debt = 1.10b EUR (from longTermDebt, last quarter)
Short Term Debt = 67.1m EUR (from shortTermDebt, last quarter)
Debt = 1.60b EUR (from shortLongTermDebtTotal, last quarter) + Leases 224.2m
Net Debt = 1.40b EUR (calculated: Debt 1.60b - CCE 201.7m)
Enterprise Value = 7.92b EUR (6.53b + Debt 1.60b - CCE 201.7m)
Interest Coverage Ratio = 8.00 (Ebit TTM 549.5m / Interest Expense TTM 68.7m)
EV/FCF = 24.71x (Enterprise Value 7.92b / FCF TTM 320.6m)
FCF Yield = 4.05% (FCF TTM 320.6m / Enterprise Value 7.92b)
FCF Margin = 14.63% (FCF TTM 320.6m / Revenue TTM 2.19b)
Net Margin = 16.28% (Net Income TTM 356.9m / Revenue TTM 2.19b)
Gross Margin = 56.10% ((Revenue TTM 2.19b - Cost of Revenue TTM 962.1m) / Revenue TTM)
Gross Margin QoQ = 50.21% (prev 55.72%)
Tobins Q-Ratio = 1.53 (Enterprise Value 7.92b / Total Assets 5.17b)
Interest Expense / Debt = 4.30% (Interest Expense 68.7m / Debt 1.60b)
Taxrate = 32.69% (40.4m / 123.6m)
NOPAT = 369.9m (EBIT 549.5m * (1 - 32.69%))
Current Ratio = 2.95 (Total Current Assets 1.42b / Total Current Liabilities 480.5m)
Debt / Equity = 0.55 (Debt 1.60b / totalStockholderEquity, last quarter 2.90b)
Debt / EBITDA = 2.08 (Net Debt 1.40b / EBITDA 672.0m)
Debt / FCF = 4.36 (Net Debt 1.40b / FCF TTM 320.6m)
Total Stockholder Equity = 2.76b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.00% (Net Income 356.9m / Total Assets 5.17b)
RoE = 12.95% (Net Income TTM 356.9m / Total Stockholder Equity 2.76b)
RoCE = 14.24% (EBIT 549.5m / Capital Employed (Equity 2.76b + L.T.Debt 1.10b))
RoIC = 8.09% (NOPAT 369.9m / Invested Capital 4.57b)
WACC = 7.95% (E(6.53b)/V(8.13b) * Re(9.19%) + D(1.60b)/V(8.13b) * Rd(4.30%) * (1-Tc(0.33)))
Discount Rate = 9.19% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -30.27 | Cagr: -0.93%
[DCF] Terminal Value 75.47% ; FCFF base≈320.3m ; Y1≈322.3m ; Y5≈342.9m
[DCF] Fair Price = 21.39 (EV 5.33b - Net Debt 1.40b = Equity 3.93b / Shares 183.9m; r=8.35% [WACC [floored]]; 5y FCF grow 0.26% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -1.78 | # QB: -1
Revenue Correlation: 99.44 | Revenue CAGR: 17.44% | SUE: 0.29 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.75 | Chg30d=+1.10% | Revisions=+16% | Analysts=18
EPS current Year (2026-09-30): EPS=1.99 | Chg30d=-2.40% | Revisions=-73% | GrowthEPS=+7.6% | GrowthRev=+11.3%
EPS next Year (2027-09-30): EPS=2.41 | Chg30d=-1.56% | Revisions=-20% | GrowthEPS=+20.8% | GrowthRev=+13.9%
[Analyst] Revisions Ratio: -73%